Zhaoke eyes $270m from Hong Kong IPO
Paul Rushton/Stripped Pixel - stock.adobe.com
Chinese company Zhaoke Ophthalmology has kicked off a Hong Kong IPO worth up to HK$2.1bn ($270m), becoming the latest biotechnology company to sell shares on the bourse.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: